QVAL vs. CNCR ETF Comparison

Comparison of ValueShares U.S. Quantitative Value ETF (QVAL) to Loncar Cancer Immunotherapy ETF (CNCR)
QVAL

ValueShares U.S. Quantitative Value ETF

QVAL Description

The investment seeks long-term capital appreciation. The fund is an actively managed ETF. Under normal circumstances, it seeks to achieve its investment objective by investing primarily in U.S. equity securities that the Adviser believes, based on quantitative analysis, are undervalued at the time of purchase and have the potential for capital appreciation. The fund will invest at least 80% of its net assets, plus any borrowings for investment purposes, in securities of U.S. companies. It will invest primarily in the exchange-listed common stock of U.S. companies. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$45.94

Average Daily Volume

19,886

Number of Holdings *

50

* may have additional holdings in another (foreign) market
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$14.81

Average Daily Volume

4,197

Number of Holdings *

67

* may have additional holdings in another (foreign) market
Performance
Period QVAL CNCR
30 Days 2.19% -1.79%
60 Days 7.26% 4.08%
90 Days 7.37% 12.50%
12 Months 28.59% 40.78%
0 Overlapping Holdings
Symbol Grade Weight in QVAL Weight in CNCR Overlap
QVAL Overweight 50 Positions Relative to CNCR
Symbol Grade Weight
POWL A 2.59%
SIG C 2.29%
WSM C 2.27%
ULTA D 2.19%
DAL B 2.19%
ASO D 2.18%
UFPI B 2.13%
KBH C 2.09%
TPR B 2.07%
CAT A 2.06%
T A 2.04%
JBL D 2.04%
BKR B 2.04%
OC B 2.04%
CMCSA B 2.03%
PCAR D 2.03%
LBRT F 2.03%
URBN F 2.02%
LEN B 2.02%
FCX B 2.02%
OMC A 2.01%
THC C 2.01%
WCC C 2.01%
HRB C 1.99%
SNA B 1.98%
MAT C 1.97%
CRI D 1.97%
CVS D 1.97%
ALSN A 1.96%
MOH D 1.95%
FOXA A 1.95%
CROX C 1.95%
GTES C 1.94%
GPK B 1.93%
SLB F 1.93%
CTSH C 1.92%
HAL F 1.9%
IPG C 1.89%
ELV F 1.88%
TAP D 1.87%
CEIX B 1.86%
MO B 1.86%
TEX F 1.85%
SKX C 1.84%
ARCH D 1.84%
SM F 1.83%
WFRD F 1.82%
MPC F 1.82%
DVN F 1.81%
CNC F 1.81%
QVAL Underweight 67 Positions Relative to CNCR
Symbol Grade Weight
SMMT D -6.48%
GERN D -3.44%
ELVN B -2.87%
NRIX D -2.41%
IGMS D -2.2%
FHTX C -2.17%
ACRV D -2.0%
RVMD B -1.88%
JANX D -1.87%
TYRA C -1.87%
KYMR C -1.78%
NUVB F -1.76%
ERAS D -1.75%
ACLX C -1.74%
REPL C -1.74%
AURA D -1.71%
BNTX B -1.71%
NUVL B -1.7%
TSVT C -1.7%
EXEL C -1.64%
REGN D -1.6%
MRUS D -1.51%
BCYC D -1.47%
BPMC F -1.44%
DAWN D -1.41%
ITOS F -1.39%
IMRX D -1.39%
IMTX D -1.38%
HCM D -1.38%
CGEM F -1.38%
GLUE D -1.37%
MRK F -1.35%
BMY B -1.34%
KURA D -1.29%
XNCR D -1.29%
RLAY F -1.28%
STRO F -1.26%
IPHA F -1.23%
YMAB D -1.22%
RCUS F -1.21%
GMAB F -1.12%
SNDX F -1.11%
IDYA F -1.06%
SDGR F -1.04%
LEGN F -0.98%
ACET F -0.98%
IOVA F -0.96%
PGEN F -0.95%
SWTX F -0.93%
LYEL F -0.91%
RPTX D -0.91%
RXRX F -0.87%
AUTL F -0.86%
ALLO F -0.84%
ARVN F -0.76%
PRLD F -0.75%
KPTI F -0.73%
IMCR F -0.72%
FATE F -0.71%
BMEA D -0.69%
VOR F -0.63%
MRSN D -0.55%
CRBU F -0.5%
GNLX D -0.49%
ZNTL D -0.4%
RAPT F -0.29%
MGNX F -0.27%
Compare ETFs